Technical Analysis for UNCY - Unicycive Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
20 DMA Resistance | Bearish | -0.92% | |
Outside Day | Range Expansion | -0.92% | |
Gapped Up | Strength | -0.92% | |
Fell Below 20 DMA | Bearish | -0.92% | |
180 Bearish Setup | Bearish Swing Setup | -0.92% | |
Crossed Above 20 DMA | Bullish | -4.42% |
Alert | Time |
---|---|
20 DMA Resistance | about 15 hours ago |
Up 1% | about 15 hours ago |
Gap Up Closed | 1 day ago |
Reversed from Up | 1 day ago |
Gapped Up (Full) | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Unicycive is a biotechnology company developing novel treatment for kidney diseases. Unicycive's lead drug, Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. UNI-494 is a patent protected new chemical entity in late preclinical development for the treatment of acute kidney injury
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Kidney Disease Kidney Nephrology Organ Failure Acute Kidney Injury Hyperphosphatemia Chemical Entity
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Kidney Disease Kidney Nephrology Organ Failure Acute Kidney Injury Hyperphosphatemia Chemical Entity
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.82 |
52 Week Low | 0.47 |
Average Volume | 378,092 |
200-Day Moving Average | 0.94 |
50-Day Moving Average | 1.27 |
20-Day Moving Average | 1.10 |
10-Day Moving Average | 1.12 |
Average True Range | 0.10 |
RSI (14) | 43.18 |
ADX | 11.28 |
+DI | 17.79 |
-DI | 19.91 |
Chandelier Exit (Long, 3 ATRs) | 1.00 |
Chandelier Exit (Short, 3 ATRs) | 1.22 |
Upper Bollinger Bands | 1.21 |
Lower Bollinger Band | 1.00 |
Percent B (%b) | 0.39 |
BandWidth | 19.71 |
MACD Line | -0.04 |
MACD Signal Line | -0.05 |
MACD Histogram | 0.0062 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.12 | ||||
Resistance 3 (R3) | 1.13 | 1.12 | 1.12 | ||
Resistance 2 (R2) | 1.12 | 1.11 | 1.12 | 1.11 | |
Resistance 1 (R1) | 1.10 | 1.10 | 1.09 | 1.09 | 1.11 |
Pivot Point | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 |
Support 1 (S1) | 1.07 | 1.08 | 1.07 | 1.07 | 1.05 |
Support 2 (S2) | 1.06 | 1.07 | 1.06 | 1.05 | |
Support 3 (S3) | 1.04 | 1.06 | 1.04 | ||
Support 4 (S4) | 1.04 |